Clinical Trials Logo

Chronic HCV Hepatitis clinical trials

View clinical trials related to Chronic HCV Hepatitis.

Filter by:
  • None
  • Page 1

NCT ID: NCT03496233 Completed - Clinical trials for Chronic HCV Hepatitis

Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in G1b Treatment-Naïve, HCV-Infected Patients

EGG-18
Start date: September 19, 2018
Phase: Phase 3
Study type: Interventional

Antiviral treatment of G1b Treatment-Naïve HCV-Infected Patients, with non- severe fibrosis, with or without insulin resistance (IR) and/or diabetes mellitus (DM) with EBR/GZR Fixed-Dose Combination for 8 Weeks.